Insulin Aspart vs Rituximab

## Insulin Aspart vs Rituximab: Overview

This comparison examines the pharmacological differences between **Insulin Aspart** and **Rituximab**.

## Mechanism of Action

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Insulin Aspart — N/A; Rituximab — 22 days.

## Chemical Properties

**Type**: Insulin Aspart — Protein; Rituximab — Antibody.